Skip to content
Bamboo Works
Search
Sign in / Register
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • Infrastructure/Resources
    • Property
  • Fast News
  • Focus Companies
    • 360 DigiTech
    • Atrenew
    • Beigene
    • Cango
    • Daqo New Energy
    • Huazhu
    • Pop Mart
    • Tuya
    • Yalla
    • Yum China
  • Expert Corner
  • Premium Content
  • China ESG Focus
  • About Us
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us
  • 简中
  • 繁中
  • Eng
Menu
  • Categories
    • IPO
    • Ecommerce
    • Finance
    • Social Media/Entertainment
    • Consumer
    • Education
    • Healthcare/biotech
    • New Energy
    • Infrastructure/Resources
    • Property
  • Fast News
  • Focus Companies
    • 360 DigiTech
    • Atrenew
    • Beigene
    • Cango
    • Daqo New Energy
    • Huazhu
    • Pop Mart
    • Tuya
    • Yalla
    • Yum China
  • Expert Corner
  • Premium Content
  • China ESG Focus
  • About Us
    • Who We Are
    • Our Writers
    • Partner with us
    • Contact Us
    • Join us

CRDMO

Wuxi AppTec finds bitter aftertaste in waning demand for Covid drug services

The leading Chinese CXO posted record revenue and strong profits last year, but its growth started to slow in the fourth quarter Key Takeaways: Wuxi AppTec’s chemical business doubled last…
March 27, 2023
2359.HK 603259.SHG

After 2022 Slowdown, WuXi Biologics Gets Growth Medicine From Big New Order

China’s leading provider of outsourced medical services said its profit and revenue rose 48.4% and 30% last year, respectively, marking a significant slowdown from the previous yearKey Takeaways:WuXi Biologics revenue…
February 21, 2023

FAST NEWS: Wuxi Bio Dives after Major Stakeholder Sells Shares

The latest: Contract drug services provider WuXi Biologics (Cayman) Inc. (2269.HK) announced on Tuesday that Biologics Holdings, one of its substantial shareholders controlled by its Chairman Li Ge, sold 56…
January 17, 2023

Buoyed by Bumper Profits, WuXi Biologics Seeks to Bolster Global Supply Chain

Drugs services provider WuXi Biologics has issued a positive earnings alert for the first half of the year, predicting revenue would rise by up to 63% and net profit would…
July 26, 2022

Recent Articles

March 27, 2023

Wuxi AppTec finds bitter aftertaste in waning demand for Covid drug services

2359.HK 603259.SHG
February 21, 2023

After 2022 Slowdown, WuXi Biologics Gets Growth Medicine From Big New Order

January 17, 2023

FAST NEWS: Wuxi Bio Dives after Major Stakeholder Sells Shares

July 26, 2022

Buoyed by Bumper Profits, WuXi Biologics Seeks to Bolster Global Supply Chain

Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo File-alt

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

Bamboo Works offers a range of partnerships for corporate and other partners, including opportunities for sponsored content, article-writing services and a wide range of promotions.

About Us
Focus Companies
Fast News
Expert Corner
Premium Content
Facebook Twitter Linkedin Weixin Weibo File-alt

Categories

  • Education
  • Finance
  • Social Media/Entertainment
  • Consumer
  • Ecommerce
  • Healthcare/biotech
  • New Energy
  • IPO
  • Infrastructure/Resources

Newsletter

For all latest news, offers and special announcements.
Signup
Copyright © 2022 Bamboo Works. All rights reserved.